Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)
Conditions
Prostate
Phase II
Volunteers
Health Professionals
What is the purpose of this trial?
The objective in this study is to determine if MRI-identified progression can decrease frequency or need for repeated prostate biopsy in men on active surveillance (AS).
Our hypothesis is that MRI alone is adequate to detect progression of prostate cancer in men on active surveillance (AS) after a MRI-US fusion prostate biopsy.
- Ages30 years - 80 years
- GenderBoth
- Trial withYale University School of Medicine
- Start Date06/11/2015
- End Date05/31/2022
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Last Updated02/15/2022
- Study HIC#1501015246